Comparison of patient subgroups with migraine or non-migraine headaches.
| Patient subgroups | Migraine n=29 | No migraine n=36 | P-value |
|---|---|---|---|
| n (%) | |||
| Age (years; mean, standard deviation) | 10.9 (2.8) | 11.1 (3.4) | 0.39 |
| Gender: male | 16 (55) | 19 (52.7) | 0.84 |
| female | 13 (44.8) | 17 (47.2) | 0.84 |
| Epilepsy syndrome: Idiopathic | 21 (72.4) | 22 (61.1) | 0.33 |
| Symptomatic | 6 (20.6) | 5 (13.8) | 0.46 |
| Type of seizure: Focal | 22 (75.8) | 25 (69.4) | 0.56 |
| Generalized | 7 (24) | 11 (30.5) | 0.56 |
| Focal seizure: occipital lobe | 3 (10.3) | 3 (8.3) | 0.78 |
| Temporal lobe | 8 (27.5) | 10 (27.7) | 0.98 |
| Parietal lobe | 1 (3.4) | 2 (5.5) | 0.68 |
| Frontal lobe | 10 (34.4) | 6 (16.6) | 0.09 |
| Medication: Carbamazepine | 12 (41.3) | 13 (36.1) | 0.66 |
| Levetiracetam | 9 (31) | 8 (22.2) | 0.42 |
| Valproic acid | 5 (17.2) | 15 (41.6) | 0.03 |
| Topiramate | 0 | 3 (8.3) | 0.24 |
| Poly-therapy | 4 (13.7) | 9 (25) | 0.35 |
| Others anti-epileptic drugs | 7 (24.1) | 6 (16) | 0.45 |